Document is current
Any future updates will be listed below
-
Authors
Scheckel, Claudia
Aguzzi, Adriano https://orcid.org/0000-0002-0344-6708
- License Information
-
More Information
Article History
First Online: 30 April 2018
Competing interests
: Adriano Aguzzi is a founder and director of Mabylon Inc., a company devoted to the development of human antibodies for treating intractable diseases, including neurodegeneration. The authors are not aware of any other affiliations, memberships, funding or financial holdings that might be perceived as affecting the objectivity of this Review.
